04/19/2024
3:26 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
3:30 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/27/2024
7:37 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/27/2024
7:26 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
7:02 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
8:19 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
2:41 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kazia Therapeutics (Subject)
| Form SC 13G | |
|
02/12/2024
5:35 PM | Kazia Therapeutics (Subject)
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
| Form SC 13G | |
02/05/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
01/18/2024
3:30 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/12/2024
3:05 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/25/2023
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
12/15/2023
4:26 PM | Kazia Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
12/15/2023
3:49 PM | Kazia Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/06/2023
7:31 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
7:30 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/29/2023
3:19 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/21/2023
3:09 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2023
3:39 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2023
8:13 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/26/2023
6:56 AM | Kazia Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
10/23/2023
7:30 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/13/2023
3:08 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2023
6:35 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2023
2:04 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2023
6:00 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023
6:00 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023
6:02 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/11/2023
6:00 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023
3:15 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2023
6:00 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2023
6:35 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/01/2023
6:14 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
